Neptune Wellness Solutions Inc. (NEPT) Social Stream
NEPTUNE WELLNESS SOLUTIONS INC (NEPT) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering NEPT.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-08-16 | 3 | $1.5 | $0.78 | $1.023 | $0.537 | 90.5% |
| 2021-11-17 | 3 | $1.5 | $0.52 | $0.873 | $0.537 | 62.57% |
| 2022-02-16 | 2 | $0.6 | $0.52 | $0.56 | $0.537 | 4.28% |
| NA | 1 | $NA | $NA | $NA | $0.537 | NA% |
Price Target Last Issued NA NA, NA
The Trend in the Analyst Price Target
NEPT's average price target has moved up $16.79 over the prior 21 months.
500 - Internal server error
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|
NEPT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2 | 1 | 0 | 1 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
NEPT's average broker recommendation rating improved by 0.33 over the prior 26 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how NEPTUNE WELLNESS SOLUTIONS INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than 24.87% of that group.
- To contextualize these metrics, consider that out of all US stocks, NEPTUNE WELLNESS SOLUTIONS INC's average analyst price target is greater than 26.52% of them.
- NEPT has a lower variance in analysts' estimates than -56.85% of Healthcare stocks.
- In terms of how NEPTUNE WELLNESS SOLUTIONS INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 232.26% of that group.
Stocks similar to NEPTUNE WELLNESS SOLUTIONS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CTMX, SYBX, and ACRS.
View All Top Stocks by Price Target
Make investment decisions regarding NEPT using the data that counts. Try POWR Ratings for free.